Skip to main content
. 2015 Aug 6;97(2):228–237. doi: 10.1016/j.ajhg.2015.06.001

Table 1.

Differences in Homozygosity Measures between Individuals with Coronary Artery Disease and Control Subjects: Combined Analysis

Measure Un-adjusted Analysis
Age-Adjusted Analysis
Age- and Sex-Adjusted Analysis
β-coefficient/OR 95% CI p Value β-coefficient/OR 95% CI p Value β-coefficient/OR 95% CI p Value
Average ROH number 0.39 0.20, 0.57 3.92 × 10−5 0.67 0.47, 0.86 4.12 × 10−11 0.63 0.42, 0.83 1.49 × 10−9
Average ROH length (kb) 2.51 −0.80, 5.82 0.14 5.19 1.64, 8.75 0.004 4.50 0.85, 8.15 0.016
Average total length of ROHs (kb) 688.11 314.44, 1,061.78 3.08 × 10−4 1,145.15 743.95, 1,546.35 2.24 × 10−8 1,046.92 634.37, 1,459.48 6.61 × 10−7
FROH 1.07 1.03, 1.10 8.63 × 10−5 1.14 1.10, 1.18 2.21 × 10−13 1.13 1.09, 1.17 1.57 × 10−11

Data for number, average length, and total length of homozygosity runs (ROHs) are β-coefficients (with respective confidence intervals and level of statistical significance [p value] from regressing homozygosity measures on case-control status with adjustment for cohort, age, and sex, where appropriate); data on FROH (proportion of autosomal genome in ROHs) are expressed as odds ratios (OR) of coronary artery disease risk (with confidence intervals and level of statistical significance) with adjustment for cohort, age, and sex (where appropriate). 95% CI indicates 95% confidence intervals.